Antimicrobial Resistance in the 21st Century

• Συγγραφή απο Οργανισμό/Αρχή: SpringerLink (Online service)
• Άλλοι συγγραφείς: Fong, I. W. (Επιμελητής έκδοσης, http://id.loc.gov/vocabulary/relators/edt), Shlaes, David (Επιμελητής έκδοσης, http://id.loc.gov/vocabulary/relators/edt), Drlica, Karl (Επιμελητής έκδοσης, http://id.loc.gov/vocabulary/relators/edt)
• Μορφή: Ηλεκτρονική πηγή Ηλ. βιβλίο
• Γλώσσα: English
• Έκδοση: Cham : Springer International Publishing : Imprint: Springer, 2018.
• Έκδοση: 2nd ed. 2018.
• Σειρά: Emerging Infectious Diseases of the 21st Century
• Θέματα: Immunology.; Infectious diseases.; Microbiology.; Virology.; Epidemiology.; Public health.; Infectious Diseases.; Public Health.

Antimicrobial resistance is now a general problem. Many of us have elderly relatives who died from a drug-resistant infection, and some of us have suffered from a resistant urinary infection that likely came from intestinal bacteria following antibiotic consumption. Antimicrobial Resistance in the...

Πίνακας περιεχομένων:

• Chapter1: Introduction : Coordinated Global Action is Needed to Combat Antimicrobial Resistance
• Part I: Examples of Resistance
• Chapter2: Antimicrobial Resistance Among Streptococcus pneumoniae
• Chapter3: Emergence of MRSA in the Community
• Chapter4: Resistance of Gram-negative Bacilli to Antimicrobials
• Chapter5: Drug Resistance in Tuberculosis
• Chapter6: Anaerobic Bacteria: Antimicrobial Susceptibility Testing and Resistance Patterns
• Chapter7: Clinical Significance and Biologic Basis of HIV Drug Resistance
• Chapter8: Resistance of Herpesviruses to Antiviral Agents
• Chapter9: Heteroresistance: A Harbinger of Future Resistance
• Part II: Biology of Resistance
• Chapter10: Epidemiology of Bacterial Resistance
• Chapter11: Transmissible Antibiotic Resistance
• Chapter12: Antibiotics and Resistance in the Environment
• Chapter13: Phenotypic Tolerance and Bacterial Persistence
• Chapter14: Staphylococcus aureus Adaptation During Infection
• Chapter15: Bacterial Signal Transduction Systems in Antimicrobial Resistance
• Chapter16: Fluoroquinolone Interactions with Bacterial Type II Topoisomerases and Target-mediated Drug Resistance
• Part III: Finding New Antimicrobials
• Chapter17: Natural Products in Antibiotic Discovery
• Chapter18: The New vs. Old Target Debate For Drug Discovery
• Chapter19: Non-quinolone Topoisomerase Inhibitors
• Chapter20: Antimicrobial-Mediated Bacterial Suicide
• Chapter21: PK/PD-based Prediction of "Anti-mutant" Antibiotic Exposures Using In Vitro Dynamic Models
• Part IV: Bringing Compounds to Market
• Chapter22: The Role of Pharmacometrics in the Development of Antimicrobial Agents
• Chapter23: New Regulatory Pathways for Antibacterial Drugs
• Chapter24: Economic Incentives for Antibacterial Drug Development: Alternative Market Structures to Promote Innovation.